Ann: Entitlement Offer Results, page-10

First 10 Last

Share
Profile

Follow
avinvest

871 Posts.

303

06/06/24

22:18

Post #: 74204078
Share

Originally posted by Kirpa: ↑

To date they can't scale in a big way. History tells you that. YOY revenue growth off a small base is pretty poor. They predominantly build hardware with software and a small manufacturing business in Australia is a very tough grind. On top of that they are incurring probably $700K a year in costs being an asx listed company.
Unless they start to rapidly grow the top line they will be ignored by the asx investors as they have been to date barring a few stalwart believers. The history is also an anchor. The lower risk play here is to take it private, save around $700K a year in costs straight off the bat and try and grow the business rapidly without all the compliance red tape that comes with being listed. How many presentations has the CEO given to try and explain the business and get the market interested? His time would be better spent doing business rather than explaining the business and flogging a dead horse on the ASX.

Expand

aren’t you the “math wizard” who told us that the net raise price of the current CR was 1.5c. Do you know that some may have sold based on that advice, when the actual net raise price was 1.95c. As such, I would quietly piss off and spook other stocks. https://hotcopper.com.au/threads/ann-entitlement-offer-to-fund-growth.7974693/page-7?post_id=73574860

That said, I would consider agreeing to taking SP3 private for say $40m. Disallowed from here.

SP3 Price at posting: 1.8¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

RNU

Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some

TX3

Canadian fieldwork yields multiple pegmatites for Trinex

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

TLX

Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug

AUG

Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree

There are more pages in this discussion • 5 more messages in this thread...

First 10 Last

Add SP3 (ASX) to my watchlist

(20min delay)
Last 2.0¢		Change 0.001(5.26%)		Mkt cap ! $5.349M

Open	High	Low	Value	Volume
1.9¢	2.0¢	1.9¢	$10.95K	550K

Buyers (Bids)

No.	Vol.	Price($)
3	546447	1.8¢

Sellers (Offers)

Price($)	Vol.	No.
2.1¢	403800	1

View Market Depth

No.	Vol.	Price($)
3	546447	0.018
4	1158050	0.017
2	335000	0.016
2	400000	0.015
1	131556	0.014

Price($)	Vol.	No.
0.021	403800	1
0.025	40000	1
0.031	31580	1
0.034	7000	1
0.045	11905	1

Last trade - 15.41pm 11/07/2024 (20 minute delay)

SP3 (ASX) Chart

Ann: Entitlement Offer Results, page-10

Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some

Canadian fieldwork yields multiple pegmatites for Trinex

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug

Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Entitlement Offer Results, page-10

Top Stories

Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some

Canadian fieldwork yields multiple pegmatites for Trinex

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug

Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News